Edition:
United States

Bayer AG (BAYRY.PK)

BAYRY.PK on OTC Markets Group

130.29USD
26 May 2017
Change (% chg)

$-0.62 (-0.47%)
Prev Close
$130.91
Open
$130.10
Day's High
$130.53
Day's Low
$130.00
Volume
51,985
Avg. Vol
88,150
52-wk High
$132.80
52-wk Low
$91.53

Select another date:

Thu, May 25 2017

Bayer, J&J to face second trial over Xarelto bleeding risks

Bayer AG and Johnson & Johnson are set to return to a New Orleans federal courthouse on Tuesday with a goal of scoring their second trial win amid thousands of lawsuits blaming injuries on the blood thinner Xarelto.

BRIEF-Evotec receives milestone as part of alliance with Bayer

* Evotec receives pre-clinical milestone as part of its endometriosis alliance with Bayer

Bayer gets FDA priority review for blood cancer drug

FRANKFURT, Germany German drugmaker Bayer won the U.S. Food and Drug Administration's priority review status for an experimental drug for a difficult to treat type of blood cancer, bolstering its development pipeline.

Bayer gets FDA priority review for blood cancer drug

FRANKFURT, Germany German drugmaker Bayer won the U.S. Food and Drug Administration's priority review status for an experimental drug for a difficult to treat type of blood cancer, bolstering its development pipeline.

Bayer gets FDA priority review for blood cancer drug

FRANKFURT, Germany, May 17 German drugmaker Bayer won the U.S. Food and Drug Administration's priority review status for an experimental drug for a difficult to treat type of blood cancer, bolstering its development pipeline.

BRIEF-FDA grants Bayer priority review for investigational compound Copanlisib

* FDA grants Bayer priority review for investigational compound Copanlisib in Follicular Lymphoma

BRIEF-FDA grants priority review to Bayer anti-cancer compound

* Says receives FDA priority review for investigational anti-cancer compound copanlisib Further company coverage:

Bayer to sell Liberty crop protection brands to get Monsanto deal passed

FRANKFURT Bayer has agreed to sell its Liberty herbicide and LibertyLink-branded seeds businesses to win antitrust approval for its acquisition of Monsanto , it said on Monday.

Bayer to sell Liberty crop protection brands to get Monsanto deal passed

FRANKFURT Bayer has agreed to sell its Liberty herbicide and LibertyLink-branded seeds businesses to win antitrust approval for its acquisition of Monsanto , it said on Monday.

UPDATE 1-Bayer to sell Liberty crop protection brands to get Monsanto deal passed

* South African regulator triggers global sale of Liberty brands

Select another date:

More From Around the Web